Lennon David Jamesinsider trades

In SEC Form 4 filings, Lennon David James is listed as CHIEF EXECUTIVE OFFICER of Whitehawk Therapeutics, Inc. (WHWK). Lennon David James reported no open-market purchases or sales in the last 90 days. The latest Form 4 transaction on record was filed on Sep 18.

Companies and roles

Company	Role	Transactions	Last filed
WHWKWhitehawk Therapeutics, Inc.	CHIEF EXECUTIVE OFFICER	2	Sep 18

Cluster buys

No cluster buy in the last 90 days included a purchase by this insider (two or more insiders buying within 14 days).

Form 4 historysince 2026-09-18

Dashed line = amended filing (Form 4/A)

Company	Traded	Filed	Type	Shares	Price	Value	Owned after	10b5-1 plan	Filing
WHWKWhitehawk Therapeutics, Inc.	Sep 15	Sep 184/A	A · derivative	193,957	$4.09	$793,284	193,957	No	Form 4/A
WHWKWhitehawk Therapeutics, Inc.	Sep 15	Sep 184/A	A · derivative	193,957	$0.00	$0	193,957	No	Form 4/A

Published from this insider's public Form 4 filings on SEC EDGAR; the name is shown as filed. Named in a filing and want this page removed? See the privacy policy.